Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 43519Generated: October 26, 2026

Methyl 4-bromo-3-oxopentanoate → Methyl cis(+/-)-[2-(4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-methoxypiperidin-1-yl)-5-methyl-1,3-thiazol-4-yl]acetate

https://huagongshe.com/reaction/43519

Reaction equation

Participants

RoleNameHCIDCharge
ReactantMethyl 4-bromo-3-oxopentanoateHCID 9815681—
ReactantHCID 86648527HCID 86648527—
ProductMethyl cis(+/-)-[2-(4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-methoxypiperidin-1-yl)-5-methyl-1,3-thiazol-4-yl]acetateHCID 8664852684%

Reaction Steps

The same operation as in Example (22b) was performed using cis(±)-N-(1-carbamothioyl-3-methoxypiperidin-4-yl)-4-chloro-5-ethyl-1H-imidazole-2-carboxamide (40 mg, 0.12 mmol) obtained in Example (65c) and methyl 4-bromo-3-oxopentanoate obtained in Example (65a) (45 mg, 0.22 mmol), to obtain 44.5 mg of the title compound (84%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08536197B2
Source datasetuspto-grants-2013_09
ORD IDord-0aeb2f4b03ca4001b54a1f3e526d0ab5
Source noteuspto-grants-2013_09